1,084 results match your criteria: "Tourette Syndrome and Other Tic Disorders"

Background: Tic disorder, a chronic neurodevelopmental disorder that typically onsets during childhood, is characterized by sudden, involuntary, rapid, and non-rhythmic motor and vocal tics. Individuals with tic disorders often experience physical health issues. The purpose of our retrospective analysis was to elucidate the common comorbid physical diseases and mental disorders and their characteristics of outpatient children with tic disorders in a large public children's hospital in China over the past 5 years.

View Article and Find Full Text PDF

Gilles de la Tourette Syndrome (GTS) is a chronic tic disorder, characterized by unwanted motor actions and vocalizations. While brain stimulation techniques show promise in reducing tic severity, optimal target networks are not well-defined. Here, we leverage datasets from two independent deep brain stimulation (DBS) cohorts and a cohort of tic-inducing lesions to infer critical networks for treatment and occurrence of tics by mapping stimulation sites and lesions to a functional connectome derived from 1,000 healthy participants.

View Article and Find Full Text PDF

Background Researcher and psychologist Kieron Philip O'Connor (1950-2019) pioneered the cognitive and behavioural approach at the Institut universitaire en santé mentale de Montréal (IUSMM). It was there that he began a career as a clinical researcher studying Tourette's syndrome (TS) and obsessive-compulsive and related disorder (OCD). At the time, apart from some behavioural approaches, little cognitive intervention was available to treat chronic tics and obsessive-compulsive disorder.

View Article and Find Full Text PDF

Neuropsychiatric comorbidities and associated factors in 182 Chinese children with tic disorders.

BMC Pediatr

December 2024

Department of Pediatrics, China-Japan Friendship Hospital, No.2 Yinghua East Street, Chaoyang District, Beijing, 100029, China.

Objective: Tic disorders (TD) often present with associated neuropsychiatric comorbidities. This study aims to examine the clinical manifestations of TD in pediatric patients and explore the spectrum and features of neuropsychiatric comorbidities among Chinese children diagnosed with TD.

Methods: A retrospective analysis was conducted on pediatric TD cases newly diagnosed at our institution, using the Mini International Neuropsychiatric Interview for Children and Adolescents 5.

View Article and Find Full Text PDF

Pain in Tourette Syndrome: A Comprehensive Review.

J Child Adolesc Psychopharmacol

November 2024

Neurology and Neurosurgery, Medical Director, Movement Disorders Neuromodulation & Brain Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Article Synopsis
  • Recent surveys indicate that a significant percentage (47%-60%) of individuals with Tourette syndrome (TS) experience pain, suggesting a need for systematic investigation into how pain affects this population.
  • The article identifies different types of pain associated with TS, including tic-related pain and suppression-related pain, while highlighting altered sensory processing as a potential underlying cause.
  • Current clinical measures often overlook pain in TS, indicating a gap in research; future studies should focus on understanding pain mechanisms and developing effective assessment methods and treatments.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the size of the placebo effect in randomized controlled trials (RCTs) for Tourette's disorder medication, using various databases for research.
  • Results showed a medium to large placebo response with specific factors (like study location and sponsorship) linked to greater placebo effects, although there was a strong correlation between placebo and drug responses.
  • The study suggests that while placebo effects are significant in Tourette's disorder, they can be managed in clinical trials to better understand the actual drug effectiveness.
View Article and Find Full Text PDF

Auditory gating and its clinical correlates in adults with chronic tic disorder and neurotypical adults.

Clin Neurophysiol

December 2024

Department of Pediatrics, Marcus Autism Center, Emory University School of Medicine, 1920 Briarcliff Rd, NE, Atlanta, GA 30329, USA. Electronic address:

Article Synopsis
  • - Over 80% of adults with chronic tic disorder (CTD) show sensory over-responsivity (SOR), which is an increased sensitivity to normal sensory stimuli, potentially linked to sensory gating impairments.
  • - The study compared sensory gating in neurotypical adults and those with CTD using clinical assessments and EEG monitoring, finding that CTD adults had higher levels of SOR but no significant differences in key auditory gating measures.
  • - Results indicated that while there was a relationship between N100 gating and SOR, sensory gating impairments may not be the main cause of SOR in CTD, suggesting the need for more research on this relationship.
View Article and Find Full Text PDF
Article Synopsis
  • The tenth annual update for the F1000Research Tics collection reviews 2023 research on Gilles de la Tourette syndrome and other tic disorders.
  • The update summarizes key findings and developments in the field over the past year.
  • The authors encourage readers to contribute article suggestions and provide feedback to enhance future research.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effectiveness of a clonidine adhesive patch for treating Tourette syndrome in a clinical trial involving 488 participants across 20 centers from 2012 to 2015.
  • Primary outcomes measured included the change in tic severity and other clinical impressions, with significant improvements noted in groups receiving higher doses of the patch (1.5 and 2.0 mg/wk) compared to a placebo.
  • Results indicated that both the 1.5 and 2.0 mg/wk doses significantly reduced tic severity and improved overall function in participants, demonstrating the efficacy of clonidine for TS.
View Article and Find Full Text PDF

Pharmacological Treatment of Tourette Disorder in Children.

J Child Adolesc Psychopharmacol

October 2024

Division of Child Neurology, Department of Neurology, University of Rochester Medical Center (URMC), Rochester, NY, USA.

Tourette disorder (TD) is a neurodevelopmental disorder characterized by childhood onset of tics lasting more than one year, with multiple motor tics and at least one phonic tic at some point during the course of the symptoms. Treatment of tics may include psychoeducation, non-pharmacologic treatment, or pharmacologic treatment. We review pharmacologic treatment here.

View Article and Find Full Text PDF

A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders.

Cells

July 2024

EuMentis Therapeutics Inc., 275 Grove Street, 2-400, Newton, MA 02466, USA.

Article Synopsis
  • Tourette syndrome is a movement disorder linked to basal ganglia dysfunction, and PDE10A inhibitors, like EM-221, may help treat it.
  • EM-221 effectively inhibited PDE10A in lab tests and showed promise in reducing hyperactivity and other behavioral issues in rats, with good safety profiles in both rats and dogs.
  • The study supports moving forward with phase 2 trials for EM-221 in humans with Tourette syndrome and related disorders, as it demonstrated high enzyme occupancy and tolerability.
View Article and Find Full Text PDF

An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms.

Expert Rev Neurother

October 2024

Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA.

Article Synopsis
  • Tourette syndrome (TS) is a childhood-onset disorder with tics, and medication is recommended when symptoms significantly impact life quality.
  • The article reviews the types of tics, diagnostic criteria, and various pharmacotherapy options, including those currently being researched.
  • Individualized treatment plans are crucial; behavioral therapy is the first choice, while medications like alpha-2 agonists, antipsychotics, and botulinum toxin injections may be considered based on severity and side effects.
View Article and Find Full Text PDF
Article Synopsis
  • A significant outbreak of mass sociogenic illness induced by social media (MSMI) was documented in Germany from 2019 to 2021, featuring functional Tourette-like behaviors (FTB).
  • A representative survey involving 2,509 individuals revealed a prevalence rate of 0.17% for probable MSMI-FTB and 0.36% for highly likely cases, indicating the issue's relevance in public health.
  • The study emphasizes the need for better education for healthcare professionals and the public to prevent misdiagnoses and ensure effective treatment for those affected by MSMI-FTB.
View Article and Find Full Text PDF

Genetic neurodevelopmental clustering and dyslexia.

Mol Psychiatry

January 2025

School of Philosophy, Psychology and Language Sciences, University of Edinburgh, Edinburgh, UK.

Dyslexia is a learning difficulty with neurodevelopmental origins, manifesting as reduced accuracy and speed in reading and spelling. It is substantially heritable and frequently co-occurs with other neurodevelopmental conditions, particularly attention deficit-hyperactivity disorder (ADHD). Here, we investigate the genetic structure underlying dyslexia and a range of psychiatric traits using results from genome-wide association studies of dyslexia, ADHD, autism, anorexia nervosa, anxiety, bipolar disorder, major depressive disorder, obsessive compulsive disorder, schizophrenia, and Tourette syndrome.

View Article and Find Full Text PDF

The antisaccadic paradigm: A complementary neuropsychological tool in basal ganglia disorders.

Cortex

September 2024

2nd Department of Neurology, Comenius University Faculty of Medicine, University Hospital Bratislava, Bratislava, Slovakia. Electronic address:

Article Synopsis
  • - The review examines how the antisaccadic task helps understand inhibitory processes in various basal ganglia disorders, like Parkinson's disease and Tourette syndrome, highlighting different saccadic profiles among them.
  • - It focuses on two key inhibitory mechanisms: one that quickly suppresses strong responses (global, pre-emptive inhibition) and another that takes longer to inhibit specific responses (slower, selective response inhibition).
  • - The antisaccadic task is useful in clinical settings for diagnosis and treatment monitoring, and future improvements should include standardizing eye-tracking methods and combining this data with other indicators of disease.
View Article and Find Full Text PDF

Transcranial sonography of subcortical structures in tic/tourette disorder.

J Psychiatr Res

August 2024

Department of Psychiatry, Neurology, Psychosomatics, and Psychotherapy in Childhood and Adolescence, Rostock University Medical Center, Rostock, Germany. Electronic address:

Article Synopsis
  • Functional neuroimaging shows increased activity in a specific brain circuit related to Tic disorders, but structural imaging presents mixed findings, with some suggesting reduced caudate nucleus sizes in children with Gilles de la Tourette syndrome.
  • This study aimed to examine whether transcranial sonography (TCS) could identify abnormalities in specific deep brain structures among children with Tic disorders or Tourette syndrome compared to healthy controls.
  • Results indicated that children with Tic disorders showed higher instances of a hyperechogenic area in the left caudate nucleus, which was associated with more frequent thought and obsessive-compulsive problems, suggesting that structural changes in the brain could be linked to these issues.
View Article and Find Full Text PDF
Article Synopsis
  • Behavior therapy is crucial for treating Tourette syndrome (TS) and chronic tic disorder (CTD), but access to this therapy and its long-term effectiveness remain unclear.* -
  • The study aimed to compare the long-term efficacy and cost-effectiveness of therapist-supported, internet-delivered exposure and response prevention (ERP) versus psychoeducation in youth with TS or CTD.* -
  • Conducted in Stockholm, the trial involved 221 participants aged 9-17, with a focus on tic severity improvement and a detailed economic evaluation of both treatment approaches.*
View Article and Find Full Text PDF
Article Synopsis
  • Researchers are looking for new treatments for Tourette syndrome (TS) because current medicines don't work well and can have bad side effects.
  • They experimented with a special drug called xanomeline on mice that have TS-like behaviors to see if it could help reduce tics.
  • The results showed that xanomeline was effective, especially by targeting certain receptors in the brain, suggesting it could be a new way to treat TS in humans.
View Article and Find Full Text PDF

Abnormal H3K4 enzyme catalytic activity and neuronal morphology caused by ASH1L mutations in individuals with Tourette syndrome.

Eur Child Adolesc Psychiatry

November 2024

Department of Neurology, Linyi People's Hospital, 27 East Section of Jiefang Road Lanshan District, Linyi, 276000, Shandong, China.

Article Synopsis
  • * The study involved five TS families, where researchers validated ASH1L mutations and used various techniques to explore how these mutations affect neuronal growth and correlate with TS traits.
  • * Findings revealed that mutations near ASH1L's catalytic domain lead to mental health issues by destabilizing the protein's structure, reducing its activity, and impairing neurite growth; further studies are needed for broader insights into TS and ASH1L's role.
View Article and Find Full Text PDF

Genome-wide association study identifies DRAM1 associated with Tourette syndrome in Taiwan.

Biomed J

December 2024

Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; School of Chinese Medicine, China Medical University, Taichung, Taiwan; Division of Genetics and Metabolism, China Medical University Children's Hospital, Taichung, Taiwan; Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan. Electronic address:

Background: Tourette syndrome (TS) is a neurodevelopmental disorder characterized by motor and vocal tics. Several susceptibility loci associated with TS have been identified previously in populations of European descent using genome-wide association studies (GWAS). However, the exact pathogenic mechanism underlying TS is unknown; additionally, the results of previous GWAS for TS were based on Western populations, which may not translate to other populations.

View Article and Find Full Text PDF

Background: To examine the association between race, ethnicity, and parental educational attainment on tic-related outcomes among Tourette Syndrome (TS) participants in the Tourette Association of America International Consortium for Genetics (TAAICG) database.

Methods: 723 participants in the TAAICG dataset aged ≤21 years were included. The relationships between tic-related outcomes and race and ethnicity were examined using linear and logistic regressions.

View Article and Find Full Text PDF

Tics can have a serious impact on the quality of life of children and their families. Behavioural therapy is an evidence-based first line treatment for tic disorders. This randomised controlled trial studied the efficacy of a brief, condensed group-based programme for children with tics (Dutch Trial Registry NL8052, 27 September 2019).

View Article and Find Full Text PDF

The role of neuroactive steroids in tic disorders.

Neurosci Biobehav Rev

May 2024

Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA. Electronic address:

Tics are sudden, repetitive movements or vocalizations. Tic disorders, such as Tourette syndrome (TS), are contributed by the interplay of genetic risk factors and environmental variables, leading to abnormalities in the functioning of the cortico-striatal-thalamo-cortical (CSTC) circuitry. Various neurotransmitter systems, such as gamma-aminobutyric acid (GABA) and dopamine, are implicated in the pathophysiology of these disorders.

View Article and Find Full Text PDF

Epilepsy and childhood psychiatric disorders: a two-sample bidirectional Mendelian randomization study.

Neurol Sci

August 2024

Department of Neurosurgery, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, No. 136, Zhongshan 2Nd Road, Yuzhong District, Chongqing, 400010, China.

Background: Observational studies have indicated that psychiatric disorders are the most common comorbidities in pediatric epilepsy. However, the existence and direction of a causal relationship between the two remains controversial. This study aims to investigate the association between common childhood psychiatric disorders and epilepsy using a two-sample, bidirectional Mendelian randomization (MR) approach.

View Article and Find Full Text PDF

A meta-analysis of transcranial magnetic stimulation in Tourette syndrome.

J Psychiatr Res

May 2024

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

There is growing enthusiasm for the treatment of neuropsychiatric disorders using neuromodulation. While some reports claim that transcranial magnetic stimulation (TMS) can be used to treat Tourette Syndrome (TS), little research exists to support this assertion. This meta-analysis examined the efficacy of TMS to reduce tic severity in patients with TS.

View Article and Find Full Text PDF